BYSI Wutah pendapatan triwulanan BeyondSpring Inc.

Simbol lan logo merek BeyondSpring Inc (BYSI)

BeyondSpring Inc. relies on the strong pricing power of plinabulin, while management seeks to expand global access to its innovative therapies. This chart of quarterly sales growth demonstrates capital dynamics, where the value of 0.00 characterizes this level. Consequently, the scientific community and investors maintain a cautious, pragmatic confidence in the asset.

BeyondSpring Inc (BYSI) - Tingkat wutah pendapatan sajrone kuartal saka 04.07.2022 nganti 19.11.2026

BeyondSpring (BYSI) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis umum perusahaan:BeyondSpring, Inc. (BYSI)
Barang unggulan beyondspringpharma.com

This indicator measures the relative dynamics of three-month revenues, transforming infrequent reports into a continuous series for the precise calculation of Sharpe and Sortino ratios. By analyzing the quarterly growth of total revenue, an investor assesses the cash flow volatility of BeyondSpring Inc. (BYSI), which is critical when scaling their unique bone marrow protection system within neutropenia therapy.

Pesaing utama

INCY - Wutah pendapatan kuartal marang kuartal|Owah-owahan pendapatan dibandhingake kuartal kepungkur HUTCHMED (HCM)|NUVB: Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Day One Bio DAWN|Wutah dodolan triwulanan MNPR|Tingkat wutah pendapatan sajrone kuartal Inhibrx Biosciences INBX|Wutah dodolan triwulanan IMAB (I-Mab Biopharma Co., Ltd.)|FENC (Fennec Pharmaceuticals Inc.) - Tambahing pendapatan triwulanan|Heron Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal NVCT (Nuvectis Pharma)|Coherus BioSciences, Inc. - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan CRBP (Corbus Pharma)|CRDF: Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal BioAtla Corp (BCAB)|Wutah pendapatan kuartal marang kuartal Lixte Biotechnology Holdings, Inc.|CTXR: Tambahing pendapatan triwulanan|Wutah pendapatan triwulanan CLRB|Wutah pendapatan triwulanan BioLineRx Corporation (BLRX)|Wutah pendapatan kuartal marang kuartal Can-Fite BioPharma, Ltd. CANF|APRE (aprea.com) - Dinamika pendapatan kuartal marang kuartal|KZIA: Wutah dodolan triwulanan|Tingkat wutah pendapatan sajrone kuartal Silexion Therapeutics|NuCana plc (NCNA) - Wutah pendapatan kuartal marang kuartal|Wutah dodolan triwulanan Chimerix, Inc|Wutah dodolan triwulanan CYCC|Wutah dodolan triwulanan G1 Therapeutics (GTHX)|Wutah pendapatan kuartal marang kuartal Kronos Bio Corporation (KRON)|Kintara - Wutah dodolan kuartal marang kuartal|Oncternal Therapeutics, Inc. - Wutah dodolan triwulanan|Owah-owahan dodolan kuartal marang kuartal PRTG (Portage)